Awareness and understanding among patients about patient safety in India: A cross-sectional questionnaire-based study

2022 ◽  
pp. 251604352110656
Author(s):  
Subhrojyoti Bhowmick ◽  
Snigdha Banerjee ◽  
Saibal Das ◽  
Abhishek Nath ◽  
Debarati Kundu ◽  
...  

Background There is a dearth of studies from India evaluating the awareness of patient safety. This study was performed to gain insight into the Indian patients’ awareness about patient safety and evaluate their willingness in promoting the same. Methods In this cross-sectional study, online interactive sessions pertaining to patient safety and patient safety culture were arranged by clinical pharmacologists for 800 urban patients post-discharge from a tertiary care hospital in India. A validated questionnaire was used, and the responses were analysed using descriptive statistics. Results A total of 635 patients [mean age, 43.2  ±  10.3 years; 385 (60.6%) males] responded. A total of 93.4% of the patients were aware of the term “patient safety” and 35.3% faced situations where they felt that patient safety was compromised. Of these patients, 64.3% reported to higher authorities when faced with such situations, while the remaining either ignored the issue or had no idea about how to deal with the same. A total of 99.2% of the patients never participated in any patient safety program; nevertheless, 94.5% of them were willing to participate in the same. Accessibility to information about patient care was deemed essential by 58.3% of the patients. Conclusions Although the overall awareness about patient safety among urban Indian patients is high, there is a lack of awareness about ways of dealing with patient safety issues. Given the high level of interest in participating in patient safety programs, such programs should routinely include patients for optimizing the chances for safer provision of health care.

Author(s):  
V Aggarwal ◽  
Shakti Kumar Gupta ◽  
S Arya ◽  
S Singh

ABSTRACT Patient safety is the absence of preventable harm to a patient during the process of healthcare (WHO). Accuracy of patient identification remains a priority focus of healthcare organization. Identifying patients accurately presents many unique challenges in today's healthcare settings. We need to understand how human factors can be used to reduce adverse events. Using a human factor approach, the human system interface can be improved by providing better designed system and processes. This involves simplifying processes, standardizing procedures, providing back up when human fails, improving communication, redesigning equipment and engendering a consciousness of behavioral organization and technological limitation that lead to error. The above study was an initiative toward simplifying processes and standardizing procedures. It was a descriptive cross-sectional study carried out between April to August 2013. The tool used was a check list made after an exhaustive review of literature and validated by experts in quality assurance from NABH accredited private hospitals. The study population of 100 people which included doctors, nurses, paramedical staff and quality managers of tertiary care public and private hospitals were approached for interaction against the back drop of the check list. Response rate was 61%. Policy was framed after incorporating inputs from responses received against the back drop of the check list. How to cite this article Singh S, Gupta SK, Arya S, Aggarwal V. To Formulate a Selective Patient Safety-related Policy for a Tertiary Care Hospital. Int J Res Foundation Hosp Healthc Adm 2014;2(2):94-102.


Author(s):  
Ashis Samuel John ◽  
Kamaxi M. Bhate

Background: Inadequate understanding by patients of medical prescription given to them adversely affects treatment compliance; which can result in treatment failure and increase the incidence of adverse effects. The study site is a tertiary care hospital in a metropolitan city and the patients attending here are particularly vulnerable in this regard both due to the heavy patient load in the outpatient department and their low socioeconomic status.Methods: This was a cross sectional study conducted in the pharmacy of K.E.M. Hospital, Mumbai over a period of 1 month. Study population included general outpatient department patients of the hospital. Patients were interviewed using a pre validated questionnaire and their knowledge of the prescription analysed under five key aspects including dose, timing, duration, side effects and purpose of each drug. Data was entered using Microsoft Excel and analyzed using SPSS 22 software.Results: The mean age of the population was 37.6, with a standard deviation of 12.4. A good overall knowledge of the prescription was present only in 12.4% patients. In 52% of patients, the level of knowledge ranged from ‘no knowledge to little knowledge’. Age and literacy had statistically significant associations with overall knowledge of prescription.Conclusions: There is a significant gap in prescription knowledge in the study population. Age and literacy of the patient has an effect on prescription knowledge.


Author(s):  
Mamatha N. ◽  
Reshma Nadaf

Background: The objective of the study was to evaluate the knowledge and attitude towards pharmacovigilance and adverse drug reaction (ADR) reporting among the undergraduates, interns and postgraduate students.Methods: This was a cross sectional study done among the undergraduates, interns and post graduate medical students at Karnataka Institute of Medical Sciences, Hubballi using a pre-validated questionnaire that included 20 questions to evaluate the participants knowledge and perception of ADR and pharmacovigilance. The questionnaire was distributed to the participants (n=606) after taking their informed consent. The data was compiled and evaluated as percentages.Results: About 52% of the participants were aware of pharmacovigilance and 38.7% knew about the purpose of pharmacovigilance programme of India. 51% of the participants have experienced ADRs during their professional practice out of which 23% have reported to the pharmacovigilance centre. The most common barrier for under-reporting was lack of time to report ADR among 34% of the participants. 31% of the participants felt that managing patient was more important than reporting ADRs. 29% of the participants gave the reason as lack of access to ADR reporting forms. 25% of the participants had difficulty to decide whether ADR has occurred or not.Conclusions: Our study strongly suggests a greater need to create an awareness among undergraduate medical students, interns and postgraduate students to improve the reporting of ADRs.


Vacunas ◽  
2020 ◽  
Vol 21 (2) ◽  
pp. 95-104 ◽  
Author(s):  
Y.M. AlGoraini ◽  
N.N. AlDujayn ◽  
M.A. AlRasheed ◽  
Y.E. Bashawri ◽  
S.S. Alsubaie ◽  
...  

Author(s):  
Nandini Chatterjee ◽  
Supratick Chakraborty ◽  
Mainak Mukhopadhyay ◽  
Sinjon Ghosh ◽  
Bikramjit Barkandaj ◽  
...  

2020 ◽  
Vol 32 (1) ◽  
Author(s):  
Nearmeen M. Rashad ◽  
Marwa G. Amer ◽  
Waleed M. Reda Ashour ◽  
Hassan M. Hassanin

Abstract Background Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system with varied clinical features. Disease-modifying drugs (DMDs) of MS associated with different types of thyroiditis. In this cross-sectional study, we aimed to assess the prevalence of thyroid dysfunction in MS and to investigate the association between DMDs and the risk of thyroiditis in MS. A cross-sectional study included 100 patients with relapsing-remitting multiple sclerosis (RRMS) in relapse, and the diagnosed was according to revised McDonald’s criteria 2010. Results Our results revealed that the prevalence of thyroiditis was 40%; autoimmune (34%) and infective (6%) among patients with RRMS in relapse and cerebellar symptoms were significantly higher in patients with thyroiditis compared to patients without thyroiditis. Regarding the association between DMDs and thyroiditis, the prevalence of patients treated with interferon-beta-1b was higher in MS patients with thyroiditis compared to MS patients without thyroiditis. However, the prevalence of patients treated with interferon-beta-1a was lower in MS patients with thyroiditis compared to MS patients without thyroiditis. In addition, we found CMV infection was more common in patients treated by interferon beta-1b and candida infection was common in patients treated by fingolimod. Conclusions Thyroiditis is commonly observed in patients with RRMS in relapse and higher prevalence of patients treated with interferon-beta-1b which is commonly associated with thyroiditis and CMV infection; however, candida thyroid infection was common in MS patients treated by fingolimod.


Sign in / Sign up

Export Citation Format

Share Document